Cheryl Gillett

Cheryl Gillett

UNVERIFIED PROFILE

Are you Cheryl Gillett?   Register this Author

Register author
Cheryl Gillett

Cheryl Gillett

Publications by authors named "Cheryl Gillett"

Are you Cheryl Gillett?   Register this Author

60Publications

1607Reads

25Profile Views

Frequency of Pathogenic Germline Variants in , and in Sporadic Lobular Breast Cancer.

Cancer Epidemiol Biomarkers Prev 2019 Jul;28(7):1162-1168

School of Cancer and Pharmaceutical Sciences, Guy's Hospital, King's College London, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-18-1102DOI Listing
July 2019

The presence of Y674/Y675 phosphorylated NTRK1 via TP53 repression of PTPN6 expression as a potential prognostic marker in neuroblastoma.

Hum Pathol 2019 04 27;86:182-192. Epub 2018 Dec 27.

Developmental Biology and Cancer Program, UCL, Great Ormond Street Institute of Child Health, London WC1N 1EH, UK. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00468177183049
Publisher Site
http://dx.doi.org/10.1016/j.humpath.2018.12.003DOI Listing
April 2019

ALIX Regulates Tumor-Mediated Immunosuppression by Controlling EGFR Activity and PD-L1 Presentation.

Cell Rep 2018 07;24(3):630-641

Richard Dimbleby Department of Cancer Research, Randall Division and Division of Cancer and Pharmaceutical Sciences, King's College London, Guy's Medical School Campus, London SE1 1UL, UK; KCL Breast Cancer Now Research Unit, Department of Research Oncology, Guy's Hospital, King's College London, London SE1 9RT, UK; UCL Cancer Institute, Paul O'Gorman Building, University College London, London WC1E 6DD, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2018.06.066DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6077252PMC
July 2018

MED12, TERT promoter and RBM15 mutations in primary and recurrent phyllodes tumours.

Br J Cancer 2018 01 9;118(2):277-284. Epub 2018 Jan 9.

School of Cancer and Pharmaceutical Sciences, Guy's Hospital, King's College London, London SE1 9RT, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/bjc.2017.450DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785756PMC
January 2018

Histological scoring of immune and stromal features in breast and axillary lymph nodes is prognostic for distant metastasis in lymph node-positive breast cancers.

J Pathol Clin Res 2018 Jan 8;4(1):39-54. Epub 2018 Jan 8.

School of Cancer and Pharmaceutical SciencesCRUK King's Health Partners Centre, King's College London, Innovation Hub, Cancer Centre at Guy's Hospital, Great Maze PondLondonUK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cjp2.87DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783956PMC
January 2018

Metformin and longevity (METAL): a window of opportunity study investigating the biological effects of metformin in localised prostate cancer.

BMC Cancer 2017 Jul 21;17(1):494. Epub 2017 Jul 21.

Division of Cancer Studies, Cancer Epidemiology Group, Research Oncology, King's College London, 3rd Floor, Bermondsey Wing, Guy's Hospital, London, SE1 9RT, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-017-3458-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520293PMC
July 2017

Splicing imbalances in basal-like breast cancer underpin perturbation of cell surface and oncogenic pathways and are associated with patients' survival.

Sci Rep 2017 01 6;7:40177. Epub 2017 Jan 6.

Guy's and St Thomas' NHS Foundation Trust and King's College London NIHR Biomedical Research Centre - Translational Bioinformatics Platform, Guy's Hospital, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep40177DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216415PMC
January 2017

Two E-selectin ligands, BST-2 and LGALS3BP, predict metastasis and poor survival of ER-negative breast cancer.

Int J Oncol 2016 Jul 13;49(1):265-75. Epub 2016 May 13.

University of Lille, INSERM, U908 - CPAC, Cell Plasticity and Cancer, Lille, Villeneuve d'Ascq, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ijo.2016.3521DOI Listing
July 2016

Family history of breast cancer and its association with disease severity and mortality.

Cancer Med 2016 05 22;5(5):942-9. Epub 2016 Jan 22.

Faculty of Life Sciences and Medicine, Division of Cancer Studies, Cancer Epidemiology Group, King's College London, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.648DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4864823PMC
May 2016

HOX transcription factors are potential targets and markers in malignant mesothelioma.

BMC Cancer 2016 Feb 11;16:85. Epub 2016 Feb 11.

Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-016-2106-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750173PMC
February 2016

Progression of breast cancer following locoregional ipsilateral recurrence: importance of interval time.

Br J Cancer 2016 01 10;114(1):88-95. Epub 2015 Dec 10.

King's College London, Division of Cancer Studies, Cancer Epidemiology Group, Guy's Hospital, 3rd Floor, Bermondsey Wing, London SE1 9RT, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/bjc.2015.314DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4716532PMC
January 2016

Big Data: the challenge for small research groups in the era of cancer genomics.

Br J Cancer 2015 Nov 22;113(10):1405-12. Epub 2015 Oct 22.

Research Oncology, Faculty of Life Sciences and Medicine, King's College London, Guy's Hospital, London SE1 9RT, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/bjc.2015.341DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4815885PMC
November 2015

Digital imaging in the immunohistochemical evaluation of the proliferation markers Ki67, MCM2 and Geminin, in early breast cancer, and their putative prognostic value.

BMC Cancer 2015 Jul 25;15:546. Epub 2015 Jul 25.

Department of Research Oncology, King's College London, Faculty of Life Science and Medicine, Division of Cancer Studies, Bermondsey Wing, Guy's Hospital, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-015-1531-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4513675PMC
July 2015

Genomic Complexity Profiling Reveals That HORMAD1 Overexpression Contributes to Homologous Recombination Deficiency in Triple-Negative Breast Cancers.

Cancer Discov 2015 May 13;5(5):488-505. Epub 2015 Mar 13.

Breakthrough Breast Cancer Research Unit, King's College London, London, United Kingdom. Department of Research Oncology, King's Health Partners AHSC, Life Sciences and Medicine, King's College London, London, United Kingdom. The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-14-1092DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490184PMC
May 2015

Therapeutic targeting of integrin αvβ6 in breast cancer.

J Natl Cancer Inst 2014 Aug 28;106(8). Epub 2014 Jun 28.

Affiliations of authors: Centre for Tumour Biology (KMM, GJT, KB, AS, SV, RB, IRH, JLJ, JFM), Cancer Screening Evaluation Group (SWD, JW, RG, PC), and Molecular Oncology and Imaging (SH, CC), John Vane Science Centre, Barts Cancer Institute, Queen Mary University of London, London, UK; Department of Histopathology, Molecular Medical Sciences, Nottingham City Hospital NHS Trust, Nottingham, UK (IOE, ARG); Cancer Sciences Division, Southampton General Hospital, Southampton, UK (GJT, DE, WJT); Department of Surgery (AMT, PQ) and Department of Pathology (LJ), Ninewells Hospital and Medical School, Dundee, UK; Hedley Atkins Breast Pathology Laboratory, Guy's Hospital, London, UK (CG); Cancer Research UK Centre for Epidemiology, Mathematics and Statistics, Wolfson Institute of Preventative Medicine, Queen Mary University of London, London, UK (AB); Biogen Idec, Cambridge, MA (SV, PHW); Oncology iMED, AstraZeneca, Macclesfield, UK (JK, STB).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dju169DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4151855PMC
August 2014

The ErbB4 CYT2 variant protects EGFR from ligand-induced degradation to enhance cancer cell motility.

Sci Signal 2014 Aug 19;7(339):ra78. Epub 2014 Aug 19.

Richard Dimbleby Department of Cancer Research, Randall Division of Cell and Molecular Biophysics, King's College London, Guy's Medical School Campus, London SE1 1UL, UK. Division of Cancer Studies, King's College London, London SE1 1UL, UK. Breakthrough Breast Cancer Research Unit, Research Oncology, King's College London, Guy's Hospital, London SE1 9RT, UK. UCL Cancer Institute, Paul O'Gorman Building, University College London, London WC1E 6BT, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/scisignal.2005157DOI Listing
August 2014

Genetic predisposition to in situ and invasive lobular carcinoma of the breast.

Authors:
Elinor Sawyer Rebecca Roylance Christos Petridis Mark N Brook Salpie Nowinski Efterpi Papouli Olivia Fletcher Sarah Pinder Andrew Hanby Kelly Kohut Patricia Gorman Michele Caneppele Julian Peto Isabel Dos Santos Silva Nichola Johnson Ruth Swann Miriam Dwek Katherine-Anne Perkins Cheryl Gillett Richard Houlston Gillian Ross Paolo De Ieso Melissa C Southey John L Hopper Elena Provenzano Carmel Apicella Jelle Wesseling Sten Cornelissen Renske Keeman Peter A Fasching Sebastian M Jud Arif B Ekici Matthias W Beckmann Michael J Kerin Federick Marme Andreas Schneeweiss Christof Sohn Barbara Burwinkel Pascal Guénel Therese Truong Pierre Laurent-Puig Pierre Kerbrat Stig E Bojesen Børge G Nordestgaard Sune F Nielsen Henrik Flyger Roger L Milne Jose Ignacio Arias Perez Primitiva Menéndez Javier Benitez Hermann Brenner Aida Karina Dieffenbach Volker Arndt Christa Stegmaier Alfons Meindl Peter Lichtner Rita K Schmutzler Magdalena Lochmann Hiltrud Brauch Hans-Peter Fischer Yon-Dschun Ko Heli Nevanlinna Taru A Muranen Kristiina Aittomäki Carl Blomqvist Natalia V Bogdanova Thilo Dörk Annika Lindblom Sara Margolin Arto Mannermaa Vesa Kataja Veli-Matti Kosma Jaana M Hartikainen Georgia Chenevix-Trench Diether Lambrechts Caroline Weltens Erik Van Limbergen Sigrid Hatse Jenny Chang-Claude Anja Rudolph Petra Seibold Dieter Flesch-Janys Paolo Radice Paolo Peterlongo Bernardo Bonanni Sara Volorio Graham G Giles Gianluca Severi Laura Baglietto Catriona A McLean Christopher A Haiman Brian E Henderson Fredrick Schumacher Loic Le Marchand Jacques Simard Mark S Goldberg France Labrèche Martine Dumont Vessela Kristensen Robert Winqvist Katri Pylkäs Arja Jukkola-Vuorinen Saila Kauppila Irene L Andrulis Julia A Knight Gord Glendon Anna Marie Mulligan Peter Devillee Rob A E M Tollenaar Caroline M Seynaeve Mieke Kriege Jonine Figueroa Stephen J Chanock Mark E Sherman Maartje J Hooning Antoinette Hollestelle Ans M W van den Ouweland Carolien H M van Deurzen Jingmei Li Kamila Czene Keith Humphreys Angela Cox Simon S Cross Malcolm W R Reed Mitul Shah Anna Jakubowska Jan Lubinski Katarzyna Jaworska-Bieniek Katarzyna Durda Anthony Swerdlow Alan Ashworth Nicholas Orr Minouk Schoemaker Fergus J Couch Emily Hallberg Anna González-Neira Guillermo Pita M Rosario Alonso Daniel C Tessier Daniel Vincent Francois Bacot Manjeet K Bolla Qin Wang Joe Dennis Kyriaki Michailidou Alison M Dunning Per Hall Doug Easton Paul Pharoah Marjanka K Schmidt Ian Tomlinson Montserrat Garcia-Closas

PLoS Genet 2014 04 17;10(4):e1004285. Epub 2014 Apr 17.

Division of Genetics and Epidemiology, Institute of Cancer Research, London, United Kingdom; Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom.

View Article

Download full-text PDF

Source
http://pubmedcentralcanada.ca/pmcc/articles/PMC3990493/pdf/p
Web Search
http://dx.plos.org/10.1371/journal.pgen.1004285
Publisher Site
http://dx.doi.org/10.1371/journal.pgen.1004285DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990493PMC
April 2014

Phosphorylation of NTRK1 at Y674/Y675 induced by TP53-dependent repression of PTPN6 expression: a potential novel prognostic marker for breast cancer.

Mod Pathol 2014 Mar 16;27(3):361-74. Epub 2013 Aug 16.

1] Immunobiology Unit, UCL, Institute of Child Health, London, UK [2] Molecular Hematology and Cancer Biology Unit, UCL, Institute of Child Health, London, UK [3] School of Health and Social Work, Department of Allied Health Professions and Midwifery University of Hertfordshire, Hatfield, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2013.129DOI Listing
March 2014

Comparison of basal-like triple-negative breast cancer defined by morphology, immunohistochemistry and transcriptional profiles.

Mod Pathol 2013 Jul 8;26(7):955-66. Epub 2013 Feb 8.

Breakthrough Breast Cancer Research Unit, King's College London, School of Medicine, Division of Cancer Studies, Bermondsey Wing, Guy's Hospital, London SE1 9RT, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2012.244DOI Listing
July 2013

The manufacture and assessment of tissue microarrays: suggestions and criteria for analysis, with breast cancer as an example.

J Clin Pathol 2013 Mar 19;66(3):169-77. Epub 2012 Oct 19.

Research Oncology, Division of Cancer Studies, King's College London, Guy's Hospital, Great Maze Pond, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jclinpath-2012-201091DOI Listing
March 2013

Targeting the HOX/PBX dimer in breast cancer.

Breast Cancer Res Treat 2012 Nov 30;136(2):389-98. Epub 2012 Sep 30.

Oncology, Institute of Bioscience and Medicine, Faculty of Health and Medical Sciences, Leggett Building, University of Surrey, Surrey, GU2 7WG, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-012-2259-2DOI Listing
November 2012

Comparative immunohistochemical analysis of ochratoxin A tumourigenesis in rats and urinary tract carcinoma in humans; mechanistic significance of p-S6 ribosomal protein expression.

Toxins (Basel) 2012 09 11;4(9):643-62. Epub 2012 Sep 11.

Breakthrough Breast Cancer Research Unit, Guy's Hospital, King's Health Partners AHSC, King's College London School of Medicine, London SE1 9RT, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/toxins4090643DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3475221PMC
September 2012

Risk factors for regional nodal relapse in breast cancer patients with one to three positive axillary nodes.

Int J Radiat Oncol Biol Phys 2012 Apr 27;82(5):2093-103. Epub 2011 Apr 27.

Guy's, King's, St Thomas' Cancer Centre, Guy's Hospital, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2011.01.066DOI Listing
April 2012

Prognosis of metachronous contralateral breast cancer: importance of stage, age and interval time between the two diagnoses.

Breast Cancer Res Treat 2011 Nov 14;130(2):609-18. Epub 2011 Jun 14.

Cancer Epidemiology Group, Division of Cancer Studies, School of Medicine, King's College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-011-1618-8DOI Listing
November 2011

Risk factors for metachronous contralateral breast cancer suggest two aetiological pathways.

Eur J Cancer 2011 Sep 12;47(13):1919-27. Epub 2011 Jun 12.

King's College London, School of Medicine, Division of Cancer Studies, Cancer Epidemiology Group, London SE1 9RT, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2011.05.004DOI Listing
September 2011

The potential of optical proteomic technologies to individualize prognosis and guide rational treatment for cancer patients.

Target Oncol 2009 Sep 16;4(3):235-52. Epub 2009 Sep 16.

Richard Dimbleby Department of Cancer Research, Randall Division & Division of Cancer Studies, Kings College London, 2nd Floor, New Hunt House, Guy's Medical School Campus, London, SE1 1UL, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11523-009-0116-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2778706PMC
September 2009

Breast tissue microarrays.

Methods Mol Med 2006 ;120:43-50

Hedley Atkins/Cancer Research UK Breast Pathology Laboratory, Guy's Hospital, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1385/1-59259-969-9:43DOI Listing
March 2006

Immunohistochemistry.

Authors:
Cheryl E Gillett

Methods Mol Med 2006 ;120:191-200

Hedley Atkins/Cancer Research UK Breast Pathology Laboratory, Guy's Hospital, London.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1385/1-59259-969-9:191DOI Listing
March 2006

Molecular cytogenetic identification of subgroups of grade III invasive ductal breast carcinomas with different clinical outcomes.

Clin Cancer Res 2004 Sep;10(18 Pt 1):5988-97

The Breakthrough Toby Robins Breast Cancer Research Centre, Institute of Cancer Research, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-03-0731DOI Listing
September 2004

A role for endothelin-2 and its receptors in breast tumor cell invasion.

Cancer Res 2004 Apr;64(7):2461-8

Cancer Research UK Translational Oncology Laboratory, Barts and The London, Queen Mary's School of Medicine and Dentistry, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.can-03-1069DOI Listing
April 2004

Human murine mammary tumour virus-like agents are genetically distinct from endogenous retroviruses and are not detectable in breast cancer cell lines or biopsies.

Virology 2004 Jan;318(1):393-404

The Department of Infectious Diseases, Guy's, King's College and St. Thomas' School of Medicine, King's College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.virol.2003.09.027DOI Listing
January 2004

The role of E-cadherin in low-grade ductal breast tumourigenesis.

J Pathol 2003 May;200(1):53-8

Molecular and Population Genetics Laboratory, Cancer Research UK, 44 Lincoln's Inn Fields, London WC2A 3PX, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.1326DOI Listing
May 2003

The Wnt pathway, epithelial-stromal interactions, and malignant progression in phyllodes tumours.

J Pathol 2002 Apr;196(4):437-44

Molecular and Population Genetics Laboratory, Imperial Cancer Research Fund, 44 Lincoln's Inn Fields, London WC2A 3PX, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.1067DOI Listing
April 2002